Product Images Fingolimod
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Fingolimod NDC 65862-952 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1: Time to 3-Month Confirmed Disability Progression – Study 1 (ITT population) - fingolimod fig1
This is a graph showing the time to 3-month confirmed disability progression in Study 1 of a medication compared to a placebo. The graph indicates the percentage of patients with progression over time, with data points at specific time intervals.*
fig2 - fingolimod fig2
Product Description: This information pertains to Fingolimod capsules containing 0.5 mg of Fingolimod hydrochloride, manufactured by Aurobindo Pharma in India. Each capsule is equivalent to 0.56 mg and is distributed under the NDC 65862-952-30. A storage temperature of 20° to 25°C (68° to 77°F) is recommended to protect the medication from moisture. Pharmacists should dispense this prescription drug in compliance with the USP Controlled Room Temperature guidelines and provide the Medication Guide separately to each patient.*
fig3 - fingolimod fig3
The text contains information about Fingolimod Capsules with a dosage of 0.5 mg. It includes details on how to store the medication, the NDC number, and instructions for pharmacists to dispense the medication. Additionally, there is a mention of a child-resistant unit-dose package.*
Chemical Structure - fingolimod str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.